Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Horstmann

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Endourology|October 19, 2007
A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy: an in-vitro pressure-measurement and microscopic studyUdo Nagele, Marcus Horstmann, Karl-Dietrich Sievert, et al.
World Journal of Urology|March 8, 2008
Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosisUdo Nagele, Markus A Kuczyk, Marcus Horstmann, et al.
World Journal of Urology|March 24, 2010
Clinical experience with survivin as a biomarker for urothelial bladder cancerMarcus Horstmann, Heike Bontrup, Jörg Hennenlotter, et al.
Anticancer Research|September 15, 2005
Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancerAxel S Merseburger, Jörg Hennenlotter, Perikles Simon, et al.
Der Urologe. Ausg. A|May 28, 2021
[What do urologist do in daily practice? : A first "unfiltered" look at patient care]Peter J Goebell, Sulafah El-Khadra, Marcus Horstmann, et al.
European Radiology|January 25, 2012
Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administrationAndreas Gutzeit, Christoph A Binkert, Dow-Mu Koh, et al.
Journal of Cancer Research and Clinical Oncology|May 10, 2017
Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detectionKarsten Salomo, Doreen Huebner, Manja U Boehme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E M van Kessel, Kirstin A van der Keur, Lars Dyrskjøt, et al.
Nature Genetics|January 3, 2025
Comprehensive genomic characterization of early-stage bladder cancerFrederik Prip, Philippe Lamy, Sia Viborg Lindskrog, et al.
European Urology|June 7, 2017
Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation StudyLars Dyrskjøt, Thomas Reinert, Ferran Algaba, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Endourology|October 19, 2007
A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy: an in-vitro pressure-measurement and microscopic studyUdo Nagele, Marcus Horstmann, Karl-Dietrich Sievert, et al.
World Journal of Urology|March 8, 2008
Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosisUdo Nagele, Markus A Kuczyk, Marcus Horstmann, et al.
World Journal of Urology|March 24, 2010
Clinical experience with survivin as a biomarker for urothelial bladder cancerMarcus Horstmann, Heike Bontrup, Jörg Hennenlotter, et al.
Anticancer Research|September 15, 2005
Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancerAxel S Merseburger, Jörg Hennenlotter, Perikles Simon, et al.
Der Urologe. Ausg. A|May 28, 2021
[What do urologist do in daily practice? : A first "unfiltered" look at patient care]Peter J Goebell, Sulafah El-Khadra, Marcus Horstmann, et al.
European Radiology|January 25, 2012
Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administrationAndreas Gutzeit, Christoph A Binkert, Dow-Mu Koh, et al.
Journal of Cancer Research and Clinical Oncology|May 10, 2017
Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detectionKarsten Salomo, Doreen Huebner, Manja U Boehme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E M van Kessel, Kirstin A van der Keur, Lars Dyrskjøt, et al.
Nature Genetics|January 3, 2025
Comprehensive genomic characterization of early-stage bladder cancerFrederik Prip, Philippe Lamy, Sia Viborg Lindskrog, et al.
European Urology|June 7, 2017
Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation StudyLars Dyrskjøt, Thomas Reinert, Ferran Algaba, et al.
Pageof 5